In AutoSet mode, the device provides only the amount of pressure required to maintain upper airway patency. The AutoSet algorithm adjusts treatment pressure as a function of inspiratory flow limitation, snore and apnea. At the same time, the device analyses the state of the patients’ upper airway on a breath-by-breath basis and delivers pressure within the allowed range according to the degree of obstruction.
Available in the AirSense 10 AutoSet and AirSense10 AutoSet for Her devices.
The pioneering new algorithm in the AirSense™ 10 AutoSet for Her is based on ResMed’s proven AutoSet algorithm and delivers therapeutic responses that have been tailored to the characteristics of obstructive sleep apnea (OSA) in women.
Research has shown that women with OSA have more upper airway resistance and flow limitation than the general OSA population1, which is why the AutoSet for Her algorithm has been designed to be more sensitive to flow limitation.
In addition, the algorithm provides more subtle changes in therapy pressure to minimise sleep disturbance. The AutoSet for Her algorithm also automatically adjusts the minimum AutoSet pressure if multiple apneas are occurring below a certain threshold.
The new AutoRamp feature with sleep onset detection helps make therapy comfortable from the moment the patient turns on their device. Built into ResMed’s AirSense 10 therapy devices, this ramp feature is activated automatically, so you’ll no longer need to spend time adjusting each patient’s ramp setting.
As soon as the patient turns on their device, AutoRamp begins – delivering a lower start pressure to help patients fall asleep with ease. Then, using its unique sleep onset detection capability, AutoRamp detects that the patient has fallen asleep, and then starts to comfortably ramp up to the prescribed pressure. So, patients receive their prescribed pressure from the moment they’ve fallen asleep.
With ramp times automatically adapting to each patient’s individual sleeping patterns, AutoRamp gives your patients a tailored start to therapy, and makes the most of every valuable moment of therapy time.
Available in the AirSense 10 Elite, AirSense 10 AutoSet for Her and AirSense 10 AutoSet devices.
CSR is a form of sleep-disordered breathing characterised by a periodic waxing and waning of respiration. The waxing periods (hypopneas, typically 40 seconds in length) can include large gasping breaths that tend to arouse the patient while the waning periods (hypopneas or apneas, typically 20 seconds in length) cause blood oxygen desaturations.
ResMed’s new Cheyne-Stokes respiration (CSR) detection feature helps you identify patients on fixed or auto-adjusting pressure devices, but who may present with CSR breathing patterns. Throughout the night, the intelligent algorithm continually monitors a patient’s breathing patterns, checking cycle lengths and searching for representations of CSR.
Available in the AirSense 10 Elite, AirSense 10 AutoSet for Her and AirSense 10 AutoSet therapy devices.
Central sleep apnea (CSA) detection uses the Forced Oscillation Technique (FOT) to determine a whether a patient’s airway is open or closed during an apnea. When an apnea has been detected, small oscillations in pressure (1 cm H2O peak-to-peak at 4 Hz) are added to the current device pressure. The CSA detection algorithm uses the resulting flow and pressure (determined at the mask) to measure whether the airway is open or closed.
Available in the AirSense 10 AutoSet, AirSense 10 AutoSet for Her and the AirSense 10 Elite.
.png?width=90&height=90&name=EIcons%20(1).png)
.png?width=90&height=90&name=R_Icons%20(1).png)